Item 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

On August 3, 2009, American Bio Medica Corporation (the "Company") received a letter of resignation from a Class II member of its Board of Directors, Daniel W. Kollin. Mr. Kollin's letter stated that his resignation was effective as of August 3, 2009. The letter did not contain any statements describing disagreements with the Company related to its operations, policies or practices, nor did any such disagreements lead to Mr. Kollin's resignation. Mr. Kollin also served on the Company's Compensation and Nominating Committees.

Rather than fill the vacancy left by Dr. Mr. Kollin's resignation, the number of directors that serve on the Company's Board of Directors was reduced from six
(6) to five (5) by resolution of the Board of Directors adopted August 6, 2009. The Company's Board of Directors continues to be comprised of a majority of independent members, with three (3) members meeting NASD's independence requirements (as independence is defined in Rule 5605(a)(2) of the NASD listing standards as applicable and as may be modified or supplemented).

To fill the vacancies created on the Compensation and Nominating Committees created when Mr. Kollin resigned, by resolution adopted August 6, 2009, the Board of Directors appointed current independent board member Jean Neff to its Compensation & Nominating Committees. As a result of these appointments, the Company's Compensation and Nominating Committees are comprised of three (3) members, all of which meet NASD's independence requirements.

---